Reykjavik, ICELAND, February 7, 2008 ― deCODE genetics (Nasdaq:DCGN) today announced that it will host a live webcast of deCODE Chief Scientific Officer Jeffrey Gulcher’s presentation at Biotechnology Industry Organization (BIO) CEO and Investor Conference.
The presentation will be delivered at 2:45 PM ET / 19:45GMT on Monday, February 11 at the Waldorf-Astoria hotel in New York. The webcast can be accessed through the Investors page on deCODE’s website, www.decode.com, and those interested in listening should log on a few minutes in advance in order to download any software or complete any sign-in that may be required. The webcast will be archived for at least one week.
About deCODE
deCODE genetics (Nasdaq:DCGN) is a global leader in applying human genetics to develop drugs and diagnostics for common diseases. Our population approach has enabled us to discover and target key biological pathways involved in conditions ranging from heart attack to cancer. We are turning these discoveries into new medicine to better treat and prevent many of the biggest challenges to public health. deCODE is delivering on the promise of the new genetics.SM Visit us on the web at
www.decode.com.
